Astec Lifesciences Limited (NSE: ASTEC, BSE: 533138) is a Mumbai, Maharashtra-based company in the Crop Protection Chemicals industry. With a market capitalisation of ₹1,191 Cr, it ranks #1,491 by market cap among the 6,197 Indian listed companies on FinBizNet, and #17 of 45 in Crop Protection Chemicals. At ₹555.00 (as of 16 Nov 2026), the share price is 41.1% below its 52-week high of ₹941.75 and 8.9% above its 52-week low of ₹509.60. The share price is down 12.8% over one year and down 8.3% over three months.
| Current Price | ₹555.00 |
|---|---|
| Market Cap | ₹1,191 Cr |
| NSE Symbol | ASTEC |
| BSE Code | 533138 |
| Sector | Materials > Chemicals > Fertilizers & Agri Chemicals |
| Sub-Industry | Fertilizers and Agricultural Chemicals > Crop Protection Chemicals |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -25.84% |
| Return on Assets | -3.38% |
| 52-Week Range | ₹509.60 – ₹941.75 |
| 1-Year Price Change | -12.8% |
| 3-Month Price Change | -8.3% |
| Beta (1Y) | 0.34 |
| Dividend Yield | 0.00% |
| Headquarters | Mumbai, Maharashtra |
| Website | www.godrejastec.com |
| Revenue | ₹72 Cr |
|---|---|
| Net Profit | ₹-37 Cr |
| Net Margin | -51.9% |
| EPS (Basic) | ₹-16.79 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Astec Lifesciences Limited reported revenue of ₹72 Cr in Q2 FY27, down 2.3% from ₹74 Cr in Q2 FY26 and down 13.8% from ₹84 Cr in Q1 FY27. It posted a net loss of ₹37 Cr for the quarter, against a net loss of ₹24 Cr in Q2 FY26. Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹72 Cr (Q2 FY27) to ₹159 Cr (Q4 FY26). The company reported a net loss in 7 of these 7 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹72 Cr | −₹37 Cr | −51.9% |
| Q1 FY27 | ₹84 Cr | −₹19 Cr | −22.4% |
| Q4 FY26 | ₹159 Cr | −₹8 Cr | −4.9% |
| Q3 FY26 | ₹125 Cr | −₹16 Cr | −12.6% |
| Q2 FY26 | ₹74 Cr | −₹24 Cr | −33.1% |
| Q1 FY26 | ₹91 Cr | −₹33 Cr | −36.3% |
| Q4 FY25 | ₹120 Cr | −₹16 Cr | −13.5% |
Consolidated figures (₹ crore, XBRL filings).
Promoters held 71.96% of Astec Lifesciences Limited's shares as of Sept 2026, against 72.42% in Sept 2025 (−0.46 percentage points). Delivery averaged 40.0% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. It also provides herbicides, insecticides, and specialty chemical products. The company also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited.
1. Agrochemicals-This segment manufactures and sells active ingredients and intermediates for agrochemicals and pharmaceutical sectors.
1. Agrochemicals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| United Phosphorus Ltd. (UPL) | ₹46,767 Cr | 24.8 | 5.61% | ₹11,860 Cr | -25.2% |
| PI Industries Ltd | ₹26,436 Cr | 20 | 12.35% | ₹1,702 Cr | -54.4% |
| Sumitomo Chemicals India Ltd | ₹17,418 Cr | 32.8 | 17.24% | ₹907 Cr | -27.1% |
| Bayer Cropscience Ltd | ₹15,609 Cr | 22.7 | 23.70% | ₹1,835 Cr | -24.9% |
| Eid Parry India Ltd | ₹11,719 Cr | 21 | 9.91% | ₹11,213 Cr | -36.1% |
| Sharda Cropchem Ltd | ₹6,457 Cr | 9.8 | 24.16% | ₹1,052 Cr | -5.9% |
| Dhanuka Agritech Ltd | ₹4,049 Cr | 14.3 | 18.62% | ₹658 Cr | -29.8% |
| Rallis India Ltd. | ₹3,680 Cr | 20.1 | 9.32% | ₹858 Cr | -23.7% |
| Astec Lifesciences Limited | ₹1,191 Cr | n/m | -25.84% | ₹72 Cr | -12.8% |
Listed by market capitalisation. Ratios are shown for context only.
Astec Lifesciences Limited is trading at ₹555.00, with a market capitalisation of ₹1,191 Cr.
Astec Lifesciences Limited operates in the Materials > Chemicals > Fertilizers & Agri Chemicals space (Fertilizers and Agricultural Chemicals > Crop Protection Chemicals).
Astec Lifesciences Limited has a return on equity of -25.84%.
Astec Lifesciences Limited is listed on the NSE under the symbol ASTEC and on the BSE under the scrip code 533138.
Astec Lifesciences Limited's share price is down 12.8% over one year and down 8.3% over three months. Its 52-week range is ₹509.60 to ₹941.75.
In Q2 FY27, Astec Lifesciences Limited reported revenue of ₹72 Cr and net profit of ₹-37 Cr, with basic EPS of ₹-16.79 (consolidated, parsed from the company's exchange filing).
Astec Lifesciences Limited reported revenue of ₹72 Cr in Q2 FY27, down 2.3% from ₹74 Cr in Q2 FY26 and down 13.8% from ₹84 Cr in Q1 FY27.
Promoters held 71.96% of Astec Lifesciences Limited's shares as of Sept 2026, against 72.42% in Sept 2025 (−0.46 percentage points).
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.